Search - Centre de Recherche en Cancérologie et Immunologie Nantes Angers Access content directly

Filter your results

52 Results
Deposit type : Notice

Leveraging the partition selection bias to achieve a high-quality clustering of mass spectra

André R.F. Silva , Diogo Lima , Louise Kurt , Mathieu Dupré , Julia Chamot-Rooke , et al.
Journal of Proteomics, 2021, 245, pp.104282. ⟨10.1016/j.jprot.2021.104282⟩
Journal articles pasteur-03441752v1

Low-count PET image reconstruction with Bayesian inference over a Deep Prior

Hernan Camilo Carrillo Lindado , Maël Millardet , Thomas Carlier , Diana Mateus
Image Processing, Feb 2021, Online Only, United States. pp.24, ⟨10.1117/12.2580169⟩
Conference papers inserm-03546657v1

Why and how antimicrobial therapy in pharmaceutical education could be taught by an integrative approach?

M. Eveillard , O. Duval , S. Legeay
Annales Pharmaceutiques Françaises, 2021, 79 (3), pp.227-229. ⟨10.1016/j.pharma.2020.10.014⟩
Journal articles hal-03209370v1

The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability

Jennifer Derrien , Catherine Guérin-Charbonnel , Victor Gaborit , Loïc Campion , Magali Devic , et al.
Genome Medicine, 2021, 13 (1), ⟨10.1186/s13073-021-00938-3⟩
Journal articles hal-03333684v1

Gene expression RNA-sequencing survival analysis of high-grade serous ovarian carcinoma: a comparative study

Elena Spirina Menand , Nisrine Jrad , Jean-Marie Marion , Alain Morel , Pierre Chauvet
2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), Dec 2021, Houston, United States. pp.3414-3419, ⟨10.1109/BIBM52615.2021.9669562⟩
Conference papers hal-03993935v1

Melflufen plus dexamethasone (dex) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) exposed/refractory to prior alkylators: A pooled analysis of the O-12-M1 and HORIZON studies.

Paula Rodríguez-Otero , Maria-Victoria Mateos , Albert Oriol , Alessandra Larocca , Joan Blade , et al.
Journal of Clinical Oncology, 2021, 39 (15_suppl), pp.8048-8048. ⟨10.1200/JCO.2021.39.15_suppl.8048⟩
Journal articles inserm-03546678v1

24th “Nantes Actualités en Transplantation” and 4th “LabEx Immunotherapy-Graft-Oncology” NAT and IGO Joint Meeting “New Horizons in Immunotherapy”

Noémie Joalland , Kathleen Ducoin , Gwenann Cadiou , Catherine Rabu , Carole Guillonneau
Frontiers in Immunology, 2021, 12 (2), pp.771-796. ⟨10.3389/fimmu.2021.738312⟩
Journal articles hal-03450492v1

Atopic dermatitis

Thomas Luger , Masayuki Amagai , Brigitte Dreno , Marie-Ange Dagnelie , Wilson Liao , et al.
Journal of Dermatological Science, 2021, 102 (3), pp.142-157. ⟨10.1016/j.jdermsci.2021.04.007⟩
Journal articles hal-03652616v1

Simulating the behaviour of Glioblastoma Multiforme based on patient MRI during treatments

Flavien Alonzo , Mazen Saad , Aurelien Serandour
Preprints, Working Papers, ... hal-03318135v1

Security and reliability of CUSTOMBONE cranioplasties: A prospective multicentric study

J-P Lejeune , M. Baroncini , P-L Henaux , Patrick Toussaint , Johann Peltier , et al.
Neurochirurgie, 2021, 67 (4), pp.301-309. ⟨10.1016/j.neuchi.2021.02.007⟩
Journal articles hal-03599580v1

Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial

Anne Bouvier , Jean-Francois Hamel , Jacques Delaunay , Eric Delabesse , Pierre-Yves Dumas , et al.
European Journal of Haematology, 2021, 107 (1), pp.111-121. ⟨10.1111/ejh.13626⟩
Journal articles hal-03604930v1

Effective Management of 177Lu-DOTA0-Tyr3-Octreotate Extravasation

Bruno Maucherat , Nicolas Varmenot , Vincent Fleury , Helene Senellart , Caroline Rousseau
Clinical Nuclear Medicine, 2021, 46 (2), pp.144-145. ⟨10.1097/RLU.0000000000003452⟩
Journal articles inserm-03540776v1

Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials

Bastien Jamet , Ludivine Morvan , Cristina Nanni , Anne-Victoire Michaud , Clément Bailly , et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 (4), pp.1005-1015. ⟨10.1007/s00259-020-05049-6⟩
Journal articles inserm-03498841v1

Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab

Mathilde Bureau , Thierry Chatellier , Tanguy Perennec , Thomas Goronflot , Charlotte Greilsamer , et al.
Cancer Immunology, Immunotherapy, 2021, Online ahead of print. ⟨10.1007/s00262-021-03108-x⟩
Journal articles inserm-03540431v1

Case Report: Grade 2 Metastatic Pancreatic Neuroendocrine Tumor With Progression of One Metastasis After Pregnancy to Grade 3 Large-Cell Neuroendocrine Carcinoma: One Case Cured by Resection With Genomic Characterization of the Two Components

Jean-Luc Raoul , Marie-Françoise Heymann , Frédéric Dumont , Alain Morel , Hélène Senellart , et al.
Frontiers in Oncology, 2021, 11, ⟨10.3389/fonc.2021.646992⟩
Journal articles hal-03623095v1

Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma

François Lemonnier , Violaine Safar , Asma Beldi-Ferchiou , Anne-Ségolène Cottereau , Emmanuel Bachy , et al.
Blood Advances, 2021, 5 (2), pp.539-548. ⟨10.1182/bloodadvances.2020003081⟩
Journal articles hal-03226483v1

IAEA Activities on 67Cu, 186Re, 47Sc Theranostic Radionuclides and Radiopharmaceuticals

Amir Jalilian , Mohamed Gizawy , Cyrille Alliot , Sandor Takacs , Sudipta Chakarborty , et al.
Current Radiopharmaceuticals, 2021, 14 (4), pp.306-314. ⟨10.2174/1874471013999200928162322⟩
Journal articles inserm-03542554v1

Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors

Catherine Ansquer , Yann Touchefeu , Alain Faivre-Chauvet , Christophe Leux , Maëlle Le Bras , et al.
Clinical Nuclear Medicine, 2021, 46 (3), pp.181-186. ⟨10.1097/RLU.0000000000003450⟩
Journal articles hal-03115018v1

Techniques for the Assessment of In Vitro and In Vivo Antifungal Combinations

Anne-Laure Bidaud , Patrick Schwarz , Guillaume Herbreteau , Eric Dannaoui
Journal of Fungi, 2021, 7 (2), pp.113. ⟨10.3390/jof7020113⟩
Journal articles hal-03950317v1

Carrying out local care for epidermal necrolysis: survey of practices

S. Ingen-Housz-Oro , R. Le Floch , A. Alves , A. Colin , R. Ouedraogo , et al.
Journal of the European Academy of Dermatology and Venereology, 2021, 35 (2), ⟨10.1111/jdv.16884⟩
Journal articles hal-03700750v1

First-line Nivolumab + Ipilimumab + Chemo in Patients With Advanced NSCLC and Brain Metastases: Results From CheckMate 9LA

D. Carbone , T. Ciuleanu , M. Cobo , M. Schenker , B. Zurawski , et al.
Journal of Thoracic Oncology, 2021, 16 (10), pp.S862. ⟨10.1016/j.jtho.2021.08.061⟩
Journal articles inserm-03540850v1

Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience

Alexis Caulier , Murielle Roussel , Pierre Morel , Naelle Lombion , Benoit Branco , et al.
Blood, 2021, 138 (25), pp.2686-2695. ⟨10.1182/blood.2021011285⟩
Journal articles hal-03578209v1

Lien entre reprogrammation métabolique et résistance à l’apoptose induites par le stroma dans les cancers du sein triple négatif

Lisa Nocquet , Kevin Louault , Ophelie Renoult , Jérôme Bourgeais , Agnes Basseville , et al.
15ème journées du cancéropôle grand-ouest, Jul 2021, Angers, France
Conference papers inserm-03319390v1

ABCL-040: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent Bruton's Tyrosine Kinase Inhibitor in Previously Treated Mantle Cell Lymphoma and Other Non-Hodgkin Lymphomas: Phase 1/2 BRUIN Study Results

Jonathon Cohen , Nirav Shah , Alvaro Alencar , James Gerson , Manish Patel , et al.
Clinical Lymphoma, Myeloma & Leukemia, 2021, 21, pp.S378-S379. ⟨10.1016/S2152-2650(21)01863-2⟩
Journal articles inserm-03546766v1

Cathepsin C inhibition as a potential treatment strategy in cancer

Brice Korkmaz , Anne-Sophie Lamort , Roxane Domain , Celine Beauvillain , Artur Gieldon , et al.
Biochemical Pharmacology, 2021, 194, pp.114803. ⟨10.1016/j.bcp.2021.114803⟩
Journal articles inserm-03547138v1

Carfilzomib in combination with daratumumab in the management of relapsed multiple myeloma

Cyrille Touzeau , Chloé Antier , Philippe Moreau
Future Oncology, 2021, 17 (9), pp.993-998. ⟨10.2217/fon-2020-0907⟩
Journal articles inserm-03496299v1

DTPA-Coated Liposomes as a New Delivery Vehicle for Plutonium Decorporation

Olivier Grémy , Marie Mougin-Degraef , Karine Devilliers , Marion Berdal , Pierre Laroche , et al.
Radiation Research, 2021, 195 (1), ⟨10.1667/RADE-20-00142.1⟩
Journal articles inserm-03540754v1

FLT3 ligand in acute myeloid leukemia: a simple test with deep implications

Pierre Peterlin , Patrice Chevallier , Steven Knapper , Matthew Collin
Leukemia & lymphoma, 2021, 62 (2), pp.264-270. ⟨10.1080/10428194.2020.1834091⟩
Journal articles inserm-03496910v1

Concomitant decrease of double-positive lymphocyte population CD4CD8αα and Faecalibacterium prausnitzii in patients with colorectal cancer

Yann Touchefeu , Emilie Duchalais , Stanislas Bruley Des Varannes , Joudy Alameddine , Eric Mirallie , et al.
European Journal of Gastroenterology & Hepatology, 2021, 32 (2), pp.149-156. ⟨10.1097/MEG.0000000000001842⟩
Journal articles inserm-03639277v1

Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: A comparison of two prospective European cohorts

Delphine Douillet , Jeremie Riou , Andrea Penaloza , Thomas Moumneh , Caroline Soulie , et al.
Thrombosis Research, 2021, 208, pp.4-10. ⟨10.1016/j.thromres.2021.10.001⟩
Journal articles hal-03439369v1